Session # 17

Pancreatitis Due to De Novo PRSS1 Pathogenic Mutations: The Ambry Genetics Experience

• PRSS1-related HP due to de novo alterations is rare; we identified this in less than 0.05% of cases (2/9,000 samples).
• Parental testing and genetic counseling should be considered for accurate risk assessment and appropriate clinical follow-up.

• Authors: Melissa Samons; Brissa Martin; Jing Wang
• Conference: PancreasFest 2017
• Date: Thursday, Jul 27, 2017 4:45pm - 5:30pm